Atlas Trials

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Clinical trial NCT00878436 · COMPLETED

Trial details

NCT number
NCT00878436
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate CancerProstatic Neoplasms
Start date
2009-06-01
Primary completion
2015-03-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.